UnitedHealth Group Incorporated $UNH Position Lifted by Keudell Morrison Wealth Management

Keudell Morrison Wealth Management lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.3% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 3,289 shares of the healthcare conglomerate’s stock after buying an additional 532 shares during the quarter. Keudell Morrison Wealth Management’s holdings in UnitedHealth Group were worth $1,026,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the business. Marietta Wealth Management LLC lifted its position in shares of UnitedHealth Group by 10.5% in the 2nd quarter. Marietta Wealth Management LLC now owns 20,872 shares of the healthcare conglomerate’s stock worth $6,511,000 after buying an additional 1,983 shares during the last quarter. Simplicity Wealth LLC lifted its position in shares of UnitedHealth Group by 141.5% in the 2nd quarter. Simplicity Wealth LLC now owns 19,077 shares of the healthcare conglomerate’s stock worth $5,952,000 after buying an additional 11,179 shares during the last quarter. Brown Miller Wealth Management LLC lifted its position in shares of UnitedHealth Group by 9.8% in the 2nd quarter. Brown Miller Wealth Management LLC now owns 7,228 shares of the healthcare conglomerate’s stock worth $2,255,000 after buying an additional 648 shares during the last quarter. OLD National Bancorp IN lifted its position in shares of UnitedHealth Group by 5.2% in the 2nd quarter. OLD National Bancorp IN now owns 53,643 shares of the healthcare conglomerate’s stock worth $16,735,000 after buying an additional 2,664 shares during the last quarter. Finally, Highland Capital Management LLC increased its holdings in shares of UnitedHealth Group by 26.8% in the 2nd quarter. Highland Capital Management LLC now owns 13,235 shares of the healthcare conglomerate’s stock worth $4,129,000 after acquiring an additional 2,800 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sanford C. Bernstein increased their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Royal Bank Of Canada dropped their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Barclays increased their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Finally, KeyCorp lowered their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $360.17 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a 50-day moving average of $307.84 and a 200-day moving average of $354.55. The firm has a market cap of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the business posted $6.80 EPS. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.